Iceland· IS-EU/1/23/1740/001-002

AREXVY

A vaccines product containing respiratory syncytial virus, glycoprotein f, recombinant, stabilised in the pre-fusion conformation, adjuvanted with as01e, registered in Iceland by GlaxoSmithKline Biologicals S.A.*. The same ATC class is registered in 2 of our 19 countries.

ATC J07

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedAREXVYATCJ07REGISTER NO.IS-EU/1/23/1740/001-0…PACKS LISTED0CHECKEDSeptember 29, 2026

Where it is registered

Respiratory syncytial virus, glycoprotein f, recombinant, stabilised in the pre-fusion conformation, adjuvanted with as01e is registered in 2 of 19 countries.

Countries holding a registration under ATC J07 (vaccines), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 2 of them publish a price we can compare per daily dose

Respiratory syncytial virus, glycoprotein f, recombinant, stabilised in the pre-fusion conformation, adjuvanted with as01e · ATC J07

2 / 19 countries

  • Finlandprice
  • Icelandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Respiratory syncytial virus, glycoprotein F, recombinant, stabilised in the pre-fusion conformation, adjuvanted with AS01E
Manufacturer
GlaxoSmithKline Biologicals S.A.*
Country
Iceland (IS)
ATC code
J07
ATC class
VACCINES
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/78e3656d-3466-4952-b261-48cb1e86946a
GET /v1/drugs/78e3656d-3466-4952-b261-48cb1e86946a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Stungulyfsstofn og dreifa, dreifa",
  "source": "lyfjastofnun",
  "atc_raw": "J07",
  "marketed": false,
  "strength": null,
  "ma_number": "EU/1/23/1740/001-002",
  "substance": "Respiratory syncytial virus, glycoprotein F, recombinant, stabilised in the pre-fusion conformation, adjuvanted with AS01E",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt",
  "ma_issued_serial": "45083"
}

See everything about respiratory syncytial virus, glycoprotein f, recombinant, stabilised in the pre-fusion conformation, adjuvanted with as01e.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.